We are live on
!
Find out more
AAF
Andra AP-fonden Portfolio holdings
AUM
$8.39B
1-Year Est. Return
21.19%
This Fund
S&P 500
This Quarter
Est. Return
-0.07%
1 Year Est. Return
+21.19%
3 Year Est. Return
+70.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.86B
AUM Growth
-$38.5M
(-0.79%)
Cap. Flow
+$72.4M
Cap. Flow
% of AUM
1.49%
Top 10 Holdings %
Top 10 Hldgs %
4.3%
Holding
618
New
24
Increased
289
Reduced
263
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$19.3M |
| 2 |
Bath & Body Works
BBWI
|
+$11.5M |
| 3 |
Chubb
CB
|
+$10.8M |
| 4 |
Upstart Holdings
UPST
|
+$10.5M |
| 5 |
AbbVie
ABBV
|
+$9.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$22M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$13.1M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$7.48M |
| 4 |
Reinsurance Group of America
RGA
|
+$7.02M |
| 5 |
XPO
XPO
|
+$6.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Healthcare | 16.68% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 12.11% |
| 5 | Industrials | 11.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Hasbro
HAS
$13.2B
| $6.8M | 0.14% |
76,200
-14,400
| -16% | -$1.4M |
|
352
FirstEnergy
FE
$27.5B
| $6.77M | 0.14% |
+190,100
| New | +$7.21M |
|
|
XYZ
353
Block Inc
XYZ
$47.5B
| $6.76M | 0.14% |
28,200
+5,400
| +24% | +$1.39M |
|
354
Moody's
MCO
$82.7B
| $6.75M | 0.14% |
19,000
-2,600
| -12% | -$980K |
|
|
SIVB
355
DELISTED
SVB Financial Group
SIVB
| $6.73M | 0.14% |
10,400
+2,400
| +30% | +$1.39M |
|
356
HubSpot
HUBS
$10.5B
| $6.69M | 0.14% |
9,900
+3,100
| +46% | +$2M |
|
357
Omega Healthcare
OHI
$14.7B
| $6.68M | 0.14% |
+223,100
| New | +$7.68M |
|
358
TJX Companies
TJX
$178B
| $6.67M | 0.14% |
101,100
-26,300
| -21% | -$1.84M |
|
359
CoStar Group
CSGP
$12.3B
| $6.63M | 0.14% |
77,000
-15,000
| -16% | -$1.3M |
|
360
JPMorgan Chase
JPM
$950B
| $6.61M | 0.14% |
40,400
+1,500
| +4% | +$235K |
|
361
Zimmer Biomet
ZBH
$18.4B
| $6.6M | 0.14% |
46,453
-16,171
| -26% | -$2.38M |
|
362
Warner Bros
WBD
$67.1B
| $6.59M | 0.14% |
259,700
-17,400
| -6% | -$489K |
|
363
M&T Bank
MTB
$36.2B
| $6.56M | 0.13% |
43,900
| – | – |
|
364
Mohawk Industries
MHK
$9.22B
| $6.53M | 0.13% |
36,800
| – | – |
|
|
BNY
365
Bank of New York Mellon
BNY
$107B
| $6.5M | 0.13% |
125,300
+7,700
| +7% | +$400K |
|
366
Amphenol
APH
$209B
| $6.48M | 0.13% |
177,000
-14,200
| -7% | -$521K |
|
367
iQIYI
IQ
$1.28B
| $6.47M | 0.13% |
806,000
+21,500
| +3% | +$223K |
|
368
PTC
PTC
$16B
| $6.35M | 0.13% |
53,000
-17,400
| -25% | -$2.32M |
|
369
Equitable Holdings
EQH
$14.1B
| $6.34M | 0.13% |
214,000
+19,700
| +10% | +$596K |
|
370
Willis Towers Watson
WTW
$32B
| $6.32M | 0.13% |
27,200
-2,000
| -7% | -$445K |
|
371
Invitation Homes
INVH
$18B
| $6.29M | 0.13% |
164,100
-26,100
| -14% | -$1.05M |
|
372
Lumen
LUMN
$6.44B
| $6.24M | 0.13% |
503,700
-127,300
| -20% | -$1.6M |
|
373
Bunge Global
BG
$20.8B
| $6.22M | 0.13% |
76,500
-14,400
| -16% | -$1.11M |
|
374
Xcel Energy
XEL
$48.8B
| $6.18M | 0.13% |
98,900
-11,800
| -11% | -$797K |
|
375
Boston Properties
BXP
$11.1B
| $6.15M | 0.13% |
56,800
-8,000
| -12% | -$914K |
|
Similar funds
NW
GGHC
FT
DM
GRQ
PCM
IC
NB
Andra AP-fonden's Q3 2021 Portfolio in Review
As of Q3 2021, Andra AP-fonden held 618 positions worth $4.86B, down 0.79% from $4.9B the previous quarter. Its ten largest holdings account for 4.3% of the portfolio.
Andra AP-fonden's Q3 2021 filing shows 24 new, 289 increased, 263 reduced and 21 closed positions. Its largest new stake was Analog Devices: 115,031 shares worth $19.3M. The largest sale was Alexion Pharmaceuticals, an estimated $22M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Andra AP-fonden's largest Q3 2021 buy was Analog Devices: 115,031 shares worth $19.3M.
- Andra AP-fonden added most to Otis Worldwide in Q3 2021, an estimated $4.8M increase.
- Andra AP-fonden's biggest Q3 2021 reduction was Jazz Pharmaceuticals, cutting an estimated $5.36M.
- Andra AP-fonden fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22M.
- Andra AP-fonden's ten largest holdings make up 4.3% of its $4.86B portfolio in Q3 2021.
- Andra AP-fonden opened 24 new positions and closed 21 in Q3 2021.
- Andra AP-fonden's portfolio value fell 0.79% quarter-over-quarter to $4.86B.
Based on Andra AP-fonden's 13F filing for Q3 2021, filed 12 Nov 2021.